Healthcare provider profile · identity verified

Yao-Chieh Cheng, MD

Internal Medicine · PHILADELPHIA, PA · NPI 1114546884

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	509	220
Amlodipine Besylate	Amlodipine Besylate	467	181
Rosuvastatin Calcium	Rosuvastatin Calcium	461	178
Gabapentin	Gabapentin	308	117
Diclofenac Sodium	Diclofenac Sodium	255	154
Losartan Potassium	Losartan Potassium	228	89
Metoprolol Succinate	Metoprolol Succinate	205	81
Metformin Hcl	Metformin Hcl	173	72
Hydrochlorothiazide	Hydrochlorothiazide	159	60
Albuterol Sulfate Hfa	Albuterol Sulfate	158	84
Metformin Hcl Er	Metformin Hcl	149	53
Fluticasone Propionate	Fluticasone Propionate	147	69
Carvedilol	Carvedilol	140	55
Omeprazole	Omeprazole	139	63
Pantoprazole Sodium	Pantoprazole Sodium	137	71
Levothyroxine Sodium	Levothyroxine Sodium	130	48
Tamsulosin Hcl	Tamsulosin Hcl	125	56
Olmesartan Medoxomil	Olmesartan Medoxomil	120	44
Lisinopril	Lisinopril	106	45
Duloxetine Hcl	Duloxetine Hcl	103	37
Alendronate Sodium	Alendronate Sodium	98	40
Famotidine	Famotidine	95	51
Ozempic	Semaglutide	89	23
Jardiance	Empagliflozin	86	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	84	24
Furosemide	Furosemide	82	42
Eliquis	Apixaban	74	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	28
Clopidogrel	Clopidogrel Bisulfate	63	23
Valsartan	Valsartan	63	23
Montelukast Sodium	Montelukast Sodium	61	27
Meloxicam	Meloxicam	60	46
Triamcinolone Acetonide	Triamcinolone Acetonide	56	32
Sertraline Hcl	Sertraline Hcl	55	16
Glipizide Er	Glipizide	54	21
Trazodone Hcl	Trazodone Hcl	54	23
Pravastatin Sodium	Pravastatin Sodium	52	21
Oxybutynin Chloride Er	Oxybutynin Chloride	49	13
Mirtazapine	Mirtazapine	48	21
Tizanidine Hcl	Tizanidine Hcl	48	29
Spironolactone	Spironolactone	47	21
Ezetimibe	Ezetimibe	46	22
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Prednisone	Prednisone	46	29
Donepezil Hcl	Donepezil Hcl	41	16
Allopurinol	Allopurinol	40	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	17
Tramadol Hcl	Tramadol Hcl	40	suppressed
Trulicity	Dulaglutide	36	suppressed
Xarelto	Rivaroxaban	36	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Metoprolol Tartrate	Metoprolol Tartrate	33	16
Simvastatin	Simvastatin	33	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Ammonium Lactate	Ammonium Lactate	31	18
Glipizide	Glipizide	30	16
Nifedipine Er	Nifedipine	30	12
Pregabalin	Pregabalin	30	12
Estradiol	Estradiol	29	11
Escitalopram Oxalate	Escitalopram Oxalate	28	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	12
Rybelsus	Semaglutide	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Incruse Ellipta	Umeclidinium Bromide	26	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Ibuprofen	Ibuprofen	24	15
Breo Ellipta	Fluticasone/Vilanterol	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Colchicine	Colchicine	21	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	15
Diazepam	Diazepam	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Nystatin	Nystatin	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Atenolol	Atenolol	17	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Restasis	Cyclosporine	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Metolazone	Metolazone	15	suppressed
Tivicay	Dolutegravir Sodium	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Naproxen	Naproxen	14	13
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	12
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Endocet	Oxycodone Hcl/Acetaminophen	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Temazepam	Temazepam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error